GLOW Blend (BPC-157 + TB-500 + GHK-Cu) 70mg

What it is

GLOW Blend is a three-ingredient formulation containing BPC-157, TB-500 and the copper-binding peptide GHK-Cu. Each branded pre-filled pen contains BPC-157 10mg, TB-500 10mg and GHK-Cu 50mg, supplied with a case.

Supply through our licensed facility does not mean the formulation itself has marketing authorisation. Prescribing is considered only after an online consultation and approval by our clinicians.

Why people ask about it

Interest in GLOW Blend often follows online discussion about skin appearance, exercise recovery and longevity. These topics explain interest in the formulation, but they are not established benefits of this blend.

Our clinicians help distinguish published findings from promotional claims, with a clear discussion of evidence gaps and whether any prescription is appropriate.

What the science says

BPC-157 literature is predominantly preclinical, with very limited human evidence. TB-500 is often discussed alongside thymosin beta-4, but findings for related preparations should not be assumed to apply to TB-500. GHK-Cu has laboratory evidence and some small human studies, including topical cosmetic studies, which do not establish outcomes for this formulation.

There is no robust clinical evidence establishing the benefits, interactions or long-term safety of this exact combination. Combining ingredients does not demonstrate that their effects are additive or that the blend is safe.

Is it right for me?

GLOW Blend is not suitable for anyone under 18, or during pregnancy or breastfeeding. Anyone with a known allergy to an ingredient should not proceed. People with active cancer or a cancer history require particular caution and specialist review because relevant safety evidence is insufficient.

Our clinicians also assess existing conditions, current medicines and supplements, previous adverse reactions and your reasons for seeking a consultation. Significant liver or kidney conditions, copper metabolism disorders or ongoing investigations may make a prescription inappropriate.

How Welcuren works

Complete a short online consultation about your health and goals.

A clinician reviews your answers, may ask follow-up questions, and decides whether this treatment is appropriate for you.

You only pay once treatment is approved. Our licensed facility then dispatches it with full instructions, on tracked global delivery.

Safety

The side-effect profile of this exact blend is not well characterised. Possible adverse effects include local discomfort, redness or swelling, headache, nausea and allergic reactions; their frequency is unknown. Interactions and longer-term risks are also uncertain, and limited reporting should not be interpreted as evidence of safety.

If prescribed, our clinicians will discuss appropriate monitoring and review, including how to report unwanted effects. Monitoring cannot remove the uncertainties associated with an unlicensed formulation. Seek urgent medical attention for breathing difficulties, facial swelling or other signs of a severe allergic reaction.